Antibody effector function is regulated by a combination of adaptive and innate signals

por Mahan, A, Dionne, K, Eusebio, J, Alter, G
Publicado 2012

P10-03. Dramatic changes in Fc-receptor expression during HIV-1 infection associated with reduced phagocytic activity during progressive HIV-1 infection

por Dugast, AM, Tonelli, A, Toth, I, Piechocka-Trocha, A, Alter, G
Publicado 2009

P10-11. NK cells do not accumulate at sites of HIV-replication but show increased activation

por Luteijn, R, Nolting, A, van Lunzen, J, Altfeld, M, Alter, G
Publicado 2009

Natural Killer cells present in gut mucosa as potential ADCC effector cells

por Sips, M, Sciaranghella, G, Tong, N, Kwon, D, Brouckaert, P, Alter, G
Publicado 2012

Antibody subclass skewing predicts enhanced ADCC activity in both natural infection and vaccination

por Dugast, A, Chung, A, Chang, Y, Licht, A, Ackerman, M, Alter, G
Publicado 2012

P10-01. MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction

por Nolting, A, Luteijn, R, Dugast, A, Carrington, M, Rihn, S, Kane, K, Jost, S, Toth, I, Faetkenheuer, G, Hartmann, P, Altfeld, M, Alter, G
Publicado 2009

P16-18. Regulatory T cell frequencies correlate with T cell activation in chronic HIV-1 infection

por Angin, M, Streeck, H, Wen, F, Pyo, A, Trocha, A, Toth, I, Kwon, D, Pereyra, F, Alter, G, Altfeld, M, Walker, BD, Addo, MM
Publicado 2009

Frequent and strong antibody-mediated NK cell activation to HIV-1 Env in individuals with chronic HIV-1 infection

por Thobakgale, C, Fadda, L, Lane, K, Toth, I, Pereyra, F, Bazner, S, Ndung'u, T, Walker, BD, Rosenberg, E, Alter, G, Carrington, M, Allen, T, Altfeld, M
Publicado 2012

Vector induced skewing of antibody Fc-effector functions

por Chung, A, Dugast, A, Robinson, H, Chan, Y, Ackerman, ME, Cox, J, Koff, W, Barouch, D, Rerks-Ngarm, S, Michael, N, Kim, J, Alter, G
Publicado 2012

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression

por Archary, D, Rong, R, Gordon, ML, Boliar, S, Gray, ES, Dugast, A, Hermanus, T, Goulder, PJ, Coovadia, HM, Morris, L, Alter, G, Derdeyn, CA, Ndung'u, T
Publicado 2012

Waning and boosting of functional humoral immunity to SARS-CoV-2

por Tong, X., McNamara, R.P., Avendaño, M.J., Serrano, E.F., García-Salum, T., Pardo-Roa, C., Levican, J., Poblete, E., Salina, E., Muñoz, A., Riquelme, A., Alter, G., Medina, R.A.
Publicado 2022

P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication

por Oniangue-Ndza, C, Schneidewind, A, Brockman, MA, Brumme, ZL, Boutwell, CL, Wang, YE, Brumme, CJ, Power, KA, Gladden, AD, Kemper, M, Le Gall, S, Streeck, H, Alter, G, Altfeld, M, Heckerman, D, Walker, BD, Allen, TM
Publicado 2009

Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

por Tong, X., McNamara, R. P., Avendaño, M. J., Serrano, E. F., García-Salum, T., Pardo-Roa, C., Bertera, H. L., Chicz, T. M., Levican, J., Poblete, E., Salinas, E., Muñoz, A., Riquelme, A., Alter, G., Medina, R. A.
Publicado 2023

Interaction of a dengue virus NS1‐derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells

por Townsley, E., O'Connor, G., Cosgrove, C., Woda, M., Co, M., Thomas, S. J., Kalayanarooj, S., Yoon, I.‐K., Nisalak, A., Srikiatkhachorn, A., Green, S., Stephens, H. A. F., Gostick, E., Price, D. A., Carrington, M., Alter, G., McVicar, D. W., Rothman, A. L., Mathew, A.
Publicado 2015